One analyst applauded Trump’s order as an “official stamp of validation” for psychedelics.

President Donald Trump signed an executive order Saturday to accelerate research for some psychedelic drugs to treat mental health disorders.

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaine